Evidence map›Paper›PMID 31686014›Full record

ArticleNature reviews. Gastroenterology & hepatology2020

Hepatocyte-stellate cell synapse in alcohol-induced steatosis: another role for endocannabinoids.

Josepmaria Argemi, Ramon Bataller

Abstract readComment
In one paragraph

Article in Nature reviews. Gastroenterology & hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Cannabinoids and the Gastrointestinal Tract.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2023
    Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Josepmaria ArgemiCenter for Liver Diseases, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0003-1696-7753
Ramon BatallerCenter for Liver Diseases, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. bataller@pitt.edu.

Funding

Pittsburgh Liver Research CenterP30DK120531 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DAVID A GELLER · 2019 to 2026
$10.9M
Alcoholic Hepatitis Consortia: an intramural/extramural collaboration to unravel genetic determinantsU01AA026264 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI BATALLER, RAMON, NAGY, LAURA E. · 2017 to 2022
$2.0M
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 7/9U01AA026978 · NIAAA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BEHARI, JAIDEEP · 2018 to 2022
$1.8M
Liver-enriched Transcription Factors as Prognostic Markers and Therapeutic Targets in Alcoholic HepatitisU01AA026972 · NIAAA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ARTEEL, GAVIN E · 2018 to 2022
$1.2M
NIAAA NIH HHS U01 AA026264NIAAA NIH HHS U01 AA026972NIAAA NIH HHS U01 AA026978NIDDK NIH HHS P30 DK120531
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

EndocannabinoidsHepatic Stellate CellsGlutamatesHepatocytesSynapsesEndocannabinoidsGlutamates

Identifiers

PMID31686014
PMCPMC7608945

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.